Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-01-02 00:00:00 ET · period of report 2026-01-02 · accession 0001193125-26-001127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-02 | 2026-01-02 | PHAT | Basta Steven L | Pres, CEO, Dir | A - Grant | $0.00 | +251.0K | 364.8K | +221% | $0 |
| D | 2026-01-02 | 2026-01-02 | PHAT | Basta Steven L | Pres, CEO, Dir | A - Grant | $0.00 | +226.2K | 221.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | A | A | 251,034 | $0.00 | 364,820 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted on January 2, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of January 2, 2026, the vesting commencement date (the "Vesting Commencement Date"), subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-01-02 | A | A | 226,156 | $0.00 | 221,156 | D | $15.71 · — to 2036-01-01 | 226,156 Common Stock | (F2) 1/48th of the total number of shares of common stock subject to the option vest monthly following the Vesting Commencement Date, subject to the Reporting Person's continuous service to the Issuer through each vesting date. |